Manufacturer record
JMM Laboratories: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by JMM Laboratories (Himachal Pradesh) were declared Not of Standard Quality between March 2024 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to JMM Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP (ZAL-M Tablets) | JMT-2504057Mfg 2025-04 · Exp 2027-03 | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay and Dissolution" for Montelukast.Assay | RDTL, GuwahatiCDSCO lab | Oct 2025 |
| Pantonis-40 (Pantoprazole Sodium Gastro Resistant Tab IP) | JMT-2407371Mfg 2024-07 · Exp 2026-06 | It fails the test ?Dissolution? as per IP, as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Diclofenac, Paracetamol and Serratiopeptidase Tablets (Pardic - SP Tables) | JMT-2208520Mfg 2022-08 · Exp 2024-07 | Assay of SerratiopeptidaseAssay | CDL KolkataCDSCO lab | Mar 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.